Head and Neck Cancer Trial, Recruiting NCT06803147 Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT06803147
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with non-dysplastic Barrett's esophagus (a condition where the lining of the food pipe changes, but without any abnormal cell changes)
  • People whose Barrett's esophagus area is shorter than 5 cm in length
  • People who have had at least one recent, good-quality camera examination of the food pipe (endoscopy), carried out properly according to standard guidelines, as determined by their specialist
  • People with no confirmed history of abnormal or pre-cancerous cell changes (called "indefinite for dysplasia" or "low-grade dysplasia") in the last 2 years or at their most recent examination, and no history of high-grade dysplasia or cancer in the Barrett's area
  • People aged 55 to 75 years old at the time of joining the trial
  • People who have given their written agreement to take part (or whose legal guardian has done so)

Who may not be able to join:

  • People who have a history of dysplasia (abnormal cell changes) in the Barrett's area, including prior cancer, prior high-grade dysplasia, or confirmed low-grade dysplasia or borderline abnormal cells in the last 2 years or at the most recent examination
  • People who have a visible lesion (an abnormal growth or area) seen during the camera examination of the food pipe
  • People who have active, severe inflammation of the food pipe (reflux esophagitis graded C or D)
  • People whose Barrett's esophagus area is less than 1 cm in length, as this group does not currently require routine monitoring
  • People with a close family member (parent, sibling, or child) who has been diagnosed with a specific type of food pipe or stomach cancer (adenocarcinoma of the esophagus or gastric cardia)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0031613396146

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Registry
ClinicalTrials.gov
Start date
1 March 2025
Est. completion
7 February 2038

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Clinical esophageal adenocarcinoma

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov